Dr. Rosalind M. Berkowitz - NPI #1720259237

Hematologist & Oncologist located in Moorestown, NJ

New Jersey Moorestown Hematology & Oncology Dr. Rosalind M. Berkowitz Information


Dr. Rosalind M. Berkowitz is a female Hematologist & Oncologist (taxonomy code 207RH0003X) located in Moorestown, New Jersey. Dr. Rosalind M. Berkowitz's NPI Number is #1720259237 and has been listed in the NPI registry for 10 years. Dr. Rosalind M. Berkowitz's practice location is listed as: 242 Hedgeman Rd Moorestown, NJ 08057-1309 and can be reached via phone at (856) 235-6533.

Hematology & Oncology Taxonomy

The taxonomy code for Dr. Rosalind M. Berkowitz's main specialty, Hematology & Oncology, is 207RH0003X. An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.



Be the first to rate Dr. Berkowitz

Thanks for sharing your opinion!

‡ Descriptions, provider messages, and reviews are user submitted. While we make our best effort to verify the accuracy of information submissions, DocBios cannot guarantee that the information is accurate and/or up to date. Please verify any and/or all information with the provider. DocBios is not an advice or referral service and does not guarantee, approve, or endorse any particular healthcare provider.

Health Care Provider Information
 NPI # 1720259237
 Phone (856) 235-6533
 Fax (856) 235-6533
242 Hedgeman Rd
Moorestown, NJ 08057-1309
 Gender F
 Website Not provided
  • Hematology & Oncology (NJ)
Business Information
  • Sole Proprietor? Yes
  • Is Sub-Organization? Not Available
  • Parent Org Name: Not Available
 Updated 3/12/2008
 Added 3/12/2008
 Viewed on 4/22/2018
Health Care Providers Nearby

Thanks! Your edit was sucessfully submitted. Changes will be displayed after DocBios.com editors have reviewed your submission.